Pain News and Research

Latest Pain News and Research

First Edition: May 12, 2014

Today's headlines include news about the inner-workings of some state-based health exchanges. Reporting for Kaiser Health News, in collaboration with NPR, Richard Knox writes: "Previous drug treatments didn't clear the virus from Bianco's system. But it's almost certain that potent new drugs for hep-C could cure him.

12 May 2014

FDA approves Bayer's Kogenate FS antihemophilic factor VIII to prevent bleeding episodes in adults with hemophilia A

Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for Bayer's Kogenate® FS antihemophilic factor VIII (recombinant), for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.

12 May 2014

Pfizer reports positive results from rLP2086 Phase 2 study for invasive meningococcal disease

Pfizer Inc. announced today the results from two Phase 2 studies of bivalent rLP2086, Pfizer's recombinant vaccine candidate, currently under development for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 to 25 year olds.

12 May 2014

Regular grape consumption may help alleviate pain linked with symptomatic osteoarthritis of knee

New research presented last week at the Experimental Biology conference in San Diego, California, suggests that regular grape consumption may help alleviate pain associated with symptomatic osteoarthritis of the knee, and improve joint flexibility and overall mobility.

12 May 2014

EU-funded project finds way to improve patients' pain treatment after surgery

Millions of people undergo surgery each year. Many of them suffer from moderate to severe pain afterwards. This post-operative pain may impede recovery or even lead on into chronic pain. Now, the EU-funded project PAIN-OUT, completed in 2012, may have found a way to improve patients' pain treatment after surgery.

9 May 2014

First Edition: May 9, 2014

Today's headlines include highlights from the first Senate confirmation hearing for Sylvia Mathews Burwell, President Barack Obama's pick for Health and Human Services Secretary.

9 May 2014

Experimental antibody temporarily halts progression of neuroblastoma in children

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody produced at St. Jude Children's Research Hospital.

9 May 2014

Shift switches pain sensor from cold-sensitive to hot-sensitive

Ice cream lovers and hot tea drinkers with sensitive teeth could one day have a reason to celebrate a new finding from Duke University researchers. The scientists have found a very small change in a single protein that turns a cold-sensitive receptor into one that senses heat.

9 May 2014

Salix Pharmaceuticals' total net product revenue increases 90% to $384.4 million in Q1 2014

Salix Pharmaceuticals, Ltd. today announced financial and operating results for the first quarter ended March 31, 2014, and other business updates.

9 May 2014

Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"

Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.

9 May 2014

Cellectricon, Neusentis to host webinar on phenotypic screening approaches in pain research

Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with Neusentis, describing the use of native cells to develop an assay with improved physiological relevance over traditional approaches in pain drug discovery research.

From Cellectricon 8 May 2014

Consumer Reports finds that only some hospitals help mothers avoid unnecessary C-sections

A Consumer Reports analysis of over 1,500 hospitals in 22 U.S. states suggests that some hospitals do a much better job than others at helping mothers avoid unnecessary C-sections.

8 May 2014

MRI-guided focused ultrasound to treat pain from bone metastases

InSightec Ltd, the leader in magnetic resonance imaging guided Focused Ultrasound therapy (MRgFUS), announced that the results of its ExAblate® Phase III clinical trial for treating painful bone metastases have been published online in the JNCI, Journal of National Cancer Institute.

8 May 2014

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Janssen R&D Ireland Ltd. (Janssen) today announced that it has expanded its collaboration with the International Partnership for Microbicides (IPM) for the development and delivery of dapivirine (TMC120) for the prevention of HIV.

8 May 2014

DC OKs health insurance tax to pay for exchange

The 1 percent tax will be imposed on all health-related insurance products sold in the nation's capital. Meanwhile, four more companies apply to sell insurance on the Washington state exchange and The Oregonian examines the reasons that state opted to participate in the federal insurance marketplace.

8 May 2014

Triple therapy shows promise for severe PAH

Results of a small pilot study among patients with severe pulmonary arterial hypertension support the long-term benefits of upfront triple combination therapy, French researchers report.

7 May 2014

Cumberland launches new Vaprisol product

Cumberland Pharmaceuticals Inc. today announced the launch of its active promotional campaign to support its new Vaprisol® product.

7 May 2014

New data presented at EADO on investigational MEK inhibitor in combination with BRAF inhibitor for metastatic melanoma

New data have been presented for the first time at the European Association of Dermato Oncology (EADO) Congress today on the investigational MEK inhibitor cobimetinib (GDC-0973) in combination with BRAFV600 inhibitor Zelboraf® (vemurafenib) for metastatic melanoma, the most aggressive form of skin cancer. The findings illustrate that cobimetinib and vemurafenib can be safely co-administered and that the combination shows promising anti-tumour activity, with a median progression-free survival (mPFS) of 13.7 months for BRAF inhibitor-naive patients.1

7 May 2014

New research aids development of better treatments for dry eye

The eye is an exquisitely sensitive system with many aspects that remain somewhat of a mystery-both in the laboratory and in the clinic.

7 May 2014

AstraZeneca’s EPANOVA receives FDA approval for treatment of adults with hypertriglyceridemia

AstraZeneca today announced the US Food and Drug Administration (FDA) approved EPANOVA (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500 mg/dL).

7 May 2014

Pain News and Research

Latest Pain News and Research

First Edition: May 12, 2014

FDA approves Bayer's Kogenate FS antihemophilic factor VIII to prevent bleeding episodes in adults with hemophilia A

Pfizer reports positive results from rLP2086 Phase 2 study for invasive meningococcal disease

Regular grape consumption may help alleviate pain linked with symptomatic osteoarthritis of knee

EU-funded project finds way to improve patients' pain treatment after surgery

First Edition: May 9, 2014

Experimental antibody temporarily halts progression of neuroblastoma in children

Shift switches pain sensor from cold-sensitive to hot-sensitive

Salix Pharmaceuticals' total net product revenue increases 90% to $384.4 million in Q1 2014

Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"

Cellectricon, Neusentis to host webinar on phenotypic screening approaches in pain research

Consumer Reports finds that only some hospitals help mothers avoid unnecessary C-sections

MRI-guided focused ultrasound to treat pain from bone metastases

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

DC OKs health insurance tax to pay for exchange

Triple therapy shows promise for severe PAH

Cumberland launches new Vaprisol product

New data presented at EADO on investigational MEK inhibitor in combination with BRAF inhibitor for metastatic melanoma

New research aids development of better treatments for dry eye

AstraZeneca’s EPANOVA receives FDA approval for treatment of adults with hypertriglyceridemia

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in